Global Health Investment Corporation

Global Health Investment Corporation, founded in 2012 and based in New York City, is an investment fund dedicated to advancing technologies that enhance human health globally. The organization provides financing to support the development of drugs, vaccines, diagnostics, and other interventions targeting critical health challenges. It has a strong focus on late-stage innovations aimed at combating infectious diseases and addressing maternal and infant health issues, which significantly contribute to morbidity and mortality in resource-limited settings. The fund has been involved in projects related to conditions such as postpartum hemorrhage, malaria, cataracts, cholera, HIV, and river blindness. To achieve its goals, the corporation employs various investment structures, including preferred equity, convertible debt, and project financing.